LEP and ovarian carcinoma: Using OVCAR-3 human ovarian cancer cell line, Chen et al. demonstrated that exogeneous leptin activates several kinase pathways such as JAK2, Akt, and ERK, all contributing to the upregulation of Mcl-1 [50].